FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114331323> ?p ?o ?g. }

• W2114331323 endingPage "2264" @default.
• W2114331323 startingPage "2258" @default.
• W2114331323 abstract "Systemic and local vascular inflammation is implicated in atherogenesis. High-sensitivity (hs) assays detecting low concentrations of C-reactive protein (CRP) in healthy individuals have delineated associations of this inflammation marker with cardiovascular events years later. A 160 309-person participant level meta-analysis of 54 prospective studies found the relationship between log-CRP concentration and cardiovascular disease (CVD) events to be linear, with a 2.5-fold risk difference in individuals at opposite extremes of the CRP distribution.1 In vitro studies and animal experiments point to potentially atherogenic actions of CRP,2 and statins lower both CRP and low-density lipoprotein cholesterol (LDL-C).3 The Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER),4 designed to ‘assess the effect of rosuvastatin on first ever cardiovascular events in apparently healthy men and women who do not qualify for statin therapy due to low levels of LDL-C, but who are at increased cardiovascular risk due to elevated levels of hs-CRP’, was halted because of ‘unequivocal evidence of a reduction in cardiovascular morbidity and mortality among patients who received CRESTOR (rosuvastatin) when compared to placebo’ (http://clinicaltrials.gov/ct2/show/[NCT00239681][1]). Consequently, the US Food and Drug Administration approved an amended license for rosuvastatin for the primary prevention of CVD events in men and women over 50 and 60 years, respectively, with one other risk factor and a CRP concentration of >2 mg/L.Even before the publication of this trial, the estimated 5 million ‘hs-CRP’ tests were being ordered annually in the USA,5 and updated Canadian guidance on CVD prevention6 now recommends the consideration of ‘hs-CRP’ measurement in those at intermediate risk. The 2010 American College of Cardiology Foundation/American Heart Association Guidelines stated that in ‘men 50 years of age or older and women 60 years of age or older with an LDL-C < 130 … [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00239681&atom=%2Fehj%2F33%2F18%2F2258.atom" @default.
• W2114331323 created "2016-06-24" @default.
• W2114331323 creator A5003345820 @default.
• W2114331323 creator A5026598177 @default.
• W2114331323 creator A5050071734 @default.
• W2114331323 creator A5050394347 @default.
• W2114331323 creator A5059407922 @default.
• W2114331323 creator A5068195667 @default.
• W2114331323 creator A5078498803 @default.
• W2114331323 creator A5081842404 @default.
• W2114331323 creator A5088521526 @default.
• W2114331323 date "2012-07-05" @default.
• W2114331323 modified "2023-10-05" @default.
• W2114331323 title "Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?" @default.
• W2114331323 cites W1458263521 @default.
• W2114331323 cites W1596038729 @default.
• W2114331323 cites W1681932403 @default.
• W2114331323 cites W1812416290 @default.
• W2114331323 cites W1970548926 @default.
• W2114331323 cites W1976553281 @default.
• W2114331323 cites W1985967126 @default.
• W2114331323 cites W1993856759 @default.
• W2114331323 cites W1995409872 @default.
• W2114331323 cites W2018427248 @default.
• W2114331323 cites W2040815013 @default.
• W2114331323 cites W2073040540 @default.
• W2114331323 cites W2080889500 @default.
• W2114331323 cites W2081615427 @default.
• W2114331323 cites W2086992282 @default.
• W2114331323 cites W2102899779 @default.
• W2114331323 cites W2110171695 @default.
• W2114331323 cites W2111563337 @default.
• W2114331323 cites W2118154631 @default.
• W2114331323 cites W2127427274 @default.
• W2114331323 cites W2130748218 @default.
• W2114331323 cites W2134824586 @default.
• W2114331323 cites W2137983259 @default.
• W2114331323 cites W2149991612 @default.
• W2114331323 cites W2150547160 @default.
• W2114331323 cites W2156543863 @default.
• W2114331323 cites W2161913081 @default.
• W2114331323 cites W2163106819 @default.
• W2114331323 cites W2163724055 @default.
• W2114331323 cites W2164089346 @default.
• W2114331323 cites W2165811650 @default.
• W2114331323 cites W2171440286 @default.
• W2114331323 cites W2247997571 @default.
• W2114331323 cites W2316243284 @default.
• W2114331323 cites W2498108824 @default.
• W2114331323 doi "https://doi.org/10.1093/eurheartj/ehs168" @default.
• W2114331323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22766581" @default.
• W2114331323 hasPublicationYear "2012" @default.
• W2114331323 type Work @default.
• W2114331323 sameAs 2114331323 @default.
• W2114331323 citedByCount "14" @default.
• W2114331323 countsByYear W21143313232013 @default.
• W2114331323 countsByYear W21143313232014 @default.
• W2114331323 countsByYear W21143313232015 @default.
• W2114331323 countsByYear W21143313232016 @default.
• W2114331323 countsByYear W21143313232019 @default.
• W2114331323 countsByYear W21143313232020 @default.
• W2114331323 countsByYear W21143313232023 @default.
• W2114331323 crossrefType "journal-article" @default.
• W2114331323 hasAuthorship W2114331323A5003345820 @default.
• W2114331323 hasAuthorship W2114331323A5026598177 @default.
• W2114331323 hasAuthorship W2114331323A5050071734 @default.
• W2114331323 hasAuthorship W2114331323A5050394347 @default.
• W2114331323 hasAuthorship W2114331323A5059407922 @default.
• W2114331323 hasAuthorship W2114331323A5068195667 @default.
• W2114331323 hasAuthorship W2114331323A5078498803 @default.
• W2114331323 hasAuthorship W2114331323A5081842404 @default.
• W2114331323 hasAuthorship W2114331323A5088521526 @default.
• W2114331323 hasBestOaLocation W21143313231 @default.
• W2114331323 hasConcept C124101348 @default.
• W2114331323 hasConcept C126322002 @default.
• W2114331323 hasConcept C164705383 @default.
• W2114331323 hasConcept C2776914184 @default.
• W2114331323 hasConcept C2779134260 @default.
• W2114331323 hasConcept C2780009758 @default.
• W2114331323 hasConcept C2781195455 @default.
• W2114331323 hasConcept C41008148 @default.
• W2114331323 hasConcept C71924100 @default.
• W2114331323 hasConcept C99454951 @default.
• W2114331323 hasConceptScore W2114331323C124101348 @default.
• W2114331323 hasConceptScore W2114331323C126322002 @default.
• W2114331323 hasConceptScore W2114331323C164705383 @default.
• W2114331323 hasConceptScore W2114331323C2776914184 @default.
• W2114331323 hasConceptScore W2114331323C2779134260 @default.
• W2114331323 hasConceptScore W2114331323C2780009758 @default.
• W2114331323 hasConceptScore W2114331323C2781195455 @default.
• W2114331323 hasConceptScore W2114331323C41008148 @default.
• W2114331323 hasConceptScore W2114331323C71924100 @default.
• W2114331323 hasConceptScore W2114331323C99454951 @default.
• W2114331323 hasIssue "18" @default.
• W2114331323 hasLocation W21143313231 @default.
• W2114331323 hasLocation W21143313232 @default.
• W2114331323 hasOpenAccess W2114331323 @default.
• W2114331323 hasPrimaryLocation W21143313231 @default.

• next